EliiGen Private Limited today announced that an independent valuation conducted by Mr. Neeraj Agarwal, a Registered Valuer (IBBI) based in Bangalore, has estimated the fair value of the company at approximately ₹100+ crore. This valuation marks a significant milestone in EliiGen’s growth journey and reflects the company’s strong fundamentals, scalable business model, and future growth potential.The valuation has been carried out in accordance with applicable valuation standards and regulatory guidelines, taking into account multiple factors such as the company’s financial performance, market positioning, intellectual assets, management capability, and projected growth prospects. The assessment underscores investor confidence in EliiGen’s strategic direction and its ability to create long-term value for stakeholders.EliiGen Private Limited has been steadily expanding its footprint, focusing on innovation, operational efficiency, and sustainable growth. The company’s leadership believes that this valuation reinforces its commitment to transparency, governance, and value creation.The detailed valuation report is available to qualified investors and strategic partners upon request and will be shared strictly under confidentiality terms. EliiGen remains open to exploring strategic collaborations and investment opportunities that align with its vision for accelerated growth and market leadership in the coming years.